Amplia Therapeutics Ltd (ASX:ATX)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ATX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ATX

  • Market CapAUD0.000m
  • SymbolASX:ATX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU0000023822

Company Profile

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.Innate Immunotherapeutics Ltd is a medical biotechnology company. It is engaged in research and development of its drug candidate (MIS416) to treat secondary progressive multiple sclerosis.

Latest ATX news

Currently there for this company. Visit our news hub for other news .